Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: Analysis of prospective randomised phase III trials-Reference-Cited by-同舟云学术

Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: Analysis of prospective randomised phase III trials

Published:2013-01 Issue:1 Volume:49 Page:142-149
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Mahner S.,Eulenburg C.,Staehle A.,Wegscheider K.,Reuss A.,Pujade-Lauraine E.,Harter P.,Ray-Coquard I.,Pfisterer J.,du Bois A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference28 articles.

1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

2. Estimates of cancer incidence and mortality in Europe in 2008;Ferlay;Eur J Cancer,2010

3. 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004);du Bois;Ann Oncol,2005

4. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials

5. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study;Winter;J Clin Oncol,2007

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk Prediction Model for Surgical Complications and Predictors of Delay/Omission of Adjuvant Chemotherapy Post Primary Cytoreduction in Epithelial Ovarian Cancer;Indian Journal of Surgery;2024-06-10

2. An Audit on Factors Delaying Time to Chemotherapy in Stage IIB–IV Ovarian Cancer Patients After Primary Debulking Surgery;Indian Journal of Gynecologic Oncology;2024-05-07

3. The impact of varying levels of residual disease following cytoreductive surgery on survival outcomes in patients with ovarian cancer: a meta-analysis;BMC Women's Health;2024-03-15

4. Cytoreduction Plus Hyperthermic Intraperitoneal Chemotherapy in Primary and Recurrent Ovarian Cancer: A Single-Center Cohort Study;Surgeries;2023-11-22

5. Correlation between progression-free survival and overall survival in patients with ovarian cancer after cytoreductive surgery: a systematic literature review;International Journal of Gynecologic Cancer;2023-08-29